Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 34,584 | N/A |
| Receivables | 18,939 | N/A |
| Inventories | 30,567 | N/A |
| Other current assets | 868 | 0 |
| TOTAL | $90,393 | $N/A |
| Non-Current Assets | ||
| PPE Net | 785 | N/A |
| Investments And Advances | 24,466 | 0 |
| Intangibles | 2,613 | 0 |
| Other Non-Current Assets | 332 | 0 |
| TOTAL | $28,196 | $N/A |
| Total Assets | $118,589 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 24,449 | 0 |
| Accrued Expenses | 8,517 | N/A |
| Other current liabilities | 3,926 | N/A |
| TOTAL | $57,618 | $N/A |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 157,780 | 0 |
| TOTAL | $157,780 | $N/A |
| Total Liabilities | $215,398 | $N/A |
| Shareholders' Equity | ||
| Retained earnings | -100,412 | N/A |
| Other shareholders' equity | 1,285 | 0 |
| TOTAL | $-96,809 | $N/A |
| Total Liabilities And Equity | $118,589 | $0 |